Skip Navigation



BJA Advance Access published online on April 2, 2004
British Journal of Anaesthesia, doi:10.1093/bja/aeh162
© 2004 by The Board of Management and Trustees of the British Journal of Anaesthesia
This Article
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
92/6/854    most recent
aeh162v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oldman, M.
Right arrow Articles by Collins, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oldman, M.
Right arrow Articles by Collins, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Accepted February 1, 2004

Clinical Investigation

Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction

M. Oldman 1*, D. Moore 2, S. Collins 1

1 Department of Anaesthesia, Anaesthetic Department, Musgrove Park Hospital, Taunton, Somerset TA1 5DA, UK
2 Department of Anaesthesia, Wellington Hospital, Capital and Coast District Health Board, Riddiford Street, Private Bag 7902, Wellington, New Zealand

* To whom correspondence should be addressed. E-mail: oldman{at}globalnet.co.uk.


  Abstract

Background. Patient information leaflets are produced for all new drugs, including anaesthetic drugs that are licensed solely for physician administration. The effect of this information on patients’ satisfaction and anxiety has not been investigated previously.

Methods. Eighty-five patients were allocated randomly to receive a standard information leaflet about anaesthesia (Group 1) or the standard leaflet plus the manufacturers’ patient information leaflets for propofol and remifentanil (Group 2). Anxiety was assessed using the state trait anxiety index (STAI) and a visual analogue scale (VAS) for anxiety before and after this information had been read. Patients’ attitudes to this information were assessed by a short questionnaire.

Results. There was no significant difference in STAI or VAS scores for anxiety between the two groups before or after the information leaflets. Significantly more patients who received drug patient information leaflets felt that they had received too much information (0% Group 1 vs 18% Group 2, P=0.003). More than 64% of patients in both groups said that they would not wish to receive detailed anaesthetic drug information. There was a correlation between the STAI and the VAS scores for anxiety (R=0.8).

Conclusions. A minority of patients (up to 36%) wish to receive detailed anaesthetic drug information before anaesthesia. Manufacturers’ drug patient information leaflets do not alter preoperative anxiety and may be safely issued to patients requesting such information.

Keywords: Keywords: anaesthesia; complications, anxiety; education, patient; monitoring, anxiety scale


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. Capuzzo, G. Gilli, L. Paparella, G. Gritti, D. Gambi, M. Bianconi, F. Giunta, C. Buccoliero, and R. Alvisi
Factors Predictive of Patient Satisfaction with Anesthesia
Anesth. Analg., August 1, 2007; 105(2): 435 - 442.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.